Quantbot Technologies LP Mannkind Corp Transaction History

Quantbot Technologies LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$2.67 - $4.77 $5,340 - $9,540	-2,000 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$3.14 - $6.14 $15,386 - $30,086	-4,900 Reduced 71.01%	2,000 $7,000
Q4 2020 Feb 12, 2021	BUY	$1.79 - $4.04 $1,253 - $2,828	700 Added 11.29%	6,900 $21,000
Q3 2020 Nov 16, 2020	BUY	$1.56 - $2.08 $3,432 - $4,576	2,200 Added 55.0%	6,200 $11,000
Q2 2020 Aug 13, 2020	BUY	$0.94 - $2.21 $3,760 - $8,840	4,000 New	4,000 $7,000

260

161M

1.97M

943K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.46B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.